Medicines and the New Economic Environment
(1998; 252 pages) [Spanish]
Table des matières
Afficher le documentTHE AUTHORS
Afficher le documentPREFACE
Afficher le documentINTRODUCTION
Ouvrir ce répertoire et afficher son contenuI. THE GLOBAL ECONOMIC ENVIRONMENT
Ouvrir ce répertoire et afficher son contenuII. THE REFORM OF HEALTH CARE SYSTEMS
Ouvrir ce répertoire et afficher son contenuIII. A CHANGING PHARMACEUTICAL INDUSTRY
Fermer ce répertoireIV. SYNTHESIS AND FORECASTS
Fermer ce répertoireMedicines and the New Economic Environment: Summary and Forecasts (*)
Fermer ce répertoire1. THE ROLE OF THE STATE AND THE REFORM OF HEALTH CARE SYSTEMS
Afficher le document1.1. Problems regarding the welfare state in Western Europe and changes in Health Care Systems
Afficher le document1.2. The development of health systems in Latin America and the ways of reform
Afficher le document1.3. Conclusions on perspectives for change in health systems
Afficher le document1.4. Cooperation from banks of development as new participants in the field of health
Ouvrir ce répertoire et afficher son contenu2. CHANGES IN THE INTERNATIONAL SCENE
Afficher le document3. CHANGES IN THE STRUCTURE OF THE PHARMACEUTICAL INDUSTRY
Afficher le document4. CALENDAR FOR FUTURE RESEARCH AND COOPERATION
Afficher le documentBIBLIOTECA CIVITAS ECONOMÍA Y EMPRESA
Afficher le documentBACK COVER
 
1.1. Problems regarding the welfare state in Western Europe and changes in Health Care Systems

In these countries the role of the State in health care has been put to task by the following factors:

a) The rise in demand for health care, partly due to the increase in levels of welfare, information and culture in society, and partly due to factors such as the rapid incorporation of new technologies;

b) The progressive ageing of society;

c) Changes in family and jobs;

d) The emergence or higher incidence of certain diseases;

e) Budget difficulties in most countries to finance social programmes.

These same elements have led to a series of reforms in health sectors, which, according to Prof. Segura's paper, aim to «increase efficiency by introducing competition in a regulated and publicly financed market». Public financing is necessary for equity reasons, while maintaining a certain degree of regulation, compatible with competition, is a consequence, according to Prof. Segura, of the special characteristics of the sector and health benefits.

Introducing competition is not, however, the only mechanism to achieve a more efficient use of resources. Prof. Mossialos refers to evidence which reveals that quite a large percentage of health services are unnecessary or are offered in an inappropriate way, and introducing or reinforcing competition would not change this situation substantially. To eliminate these inefficiencies it is not enough to have greater competition. Medical treatments and procedures must be evaluated in order to identify which services and benefits are effective and which ones are not. This is, however, a formidable task which requires many years and great expense. Its achievement would therefore greatly benefit from international cooperation.

Another field which clearly needs a common approach and greater cooperation between countries is the evaluation of new technology, in order to overcome the present state of uncoordination with multiple studies using different criteria sometimes inconsistent or inappropriate.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013